Modern Pathology, Published online: 07 October 2022; doi:10.1038/s41379-022-01167-8 Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms
Esther Conde, Susana Hernandez, Fernando Lopez-Rios. Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms. // Modern Pathology. – 2022. – DOI: 10.1038/s41379-022-01167-8. – URL: https://www.nature.com/articles/s41379-022-01167-8
Esther Conde, Susana Hernandez, & Fernando Lopez-Rios (2022). Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms. Modern Pathology. https://doi.org/10.1038/s41379-022-01167-8
Esther Conde, et al. “Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms.” Modern Pathology, 2022. doi:10.1038/s41379-022-01167-8.
@article{Conde2022,
title = {Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms},
author = {Conde, Esther and Hernandez, Susana and Lopez-Rios, Fernando},
journal = {Modern Pathology},
year = {2022},
doi = {10.1038/s41379-022-01167-8},
url = {https://www.nature.com/articles/s41379-022-01167-8}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....